# Treatment of Early Systemic Sclerosis by Bosentan

> **NCT00226889** · PHASE1,PHASE2 · TERMINATED · sponsor: **Rikshospitalet University Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Systemic Sclerosis (Scleroderma)

## Interventions

- **DRUG:** bosentan

## Key facts

- **NCT ID:** NCT00226889
- **Lead sponsor:** Rikshospitalet University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-01
- **Primary completion:** 2009-01
- **Final completion:** 2009-06
- **Target enrollment:** 30 (ESTIMATED)
- **Why stopped:** failure of recruiting a sufficient number of patients
- **Last updated:** 2009-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00226889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00226889, "Treatment of Early Systemic Sclerosis by Bosentan". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00226889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*